All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. Currently, many young people go undiagnosed and risk developing a life-threatening complication called diabetic ketoacidosis that needs urgent hospital treatment. Identifying diabetes earlier could help avoid this and mean treatments to control problematic blood sugar levels can be given sooner. Some 17,000 children aged three to 13 have already been checked as part of the ELSA (Early Surveillance for Autoimmune diabetes) study, funded by diabetes charities. Imogen, who is 12 and from the West Midlands, is one of those found to have diabetes thanks to the screening.

Senator accused of steamy affair with her bodyguard in bombshell lawsuit from his WIFE: 'Bring MDMA so I can guide you' Socialite who accused playboy twins of sex attack at Hamptons'castle' is found dead in unexplained circumstances Amy Schumer's friends reveal true meaning of thin bikini pictures and why they're'monitoring her'... as depth of ex Chris Fischer's heartbreak is laid bare Hunter Biden's stripper baby mama asks for him to be ARRESTED over claims he is still failing to pay her child support Ellen Greenberg's fiancé Sam Goldberg breaks cover as feds reopen probe into her'suicide'... and late teacher's mother shares incredible sign sent from beyond the grave Nicole Richie addresses her daughter's new identity after unveiling transformation on her 18th birthday '90s Vogue model Niki Taylor looks amazing as she sizzles at age 50 for new campaign Karoline Leavitt reveals the thinking behind Trump's call to cancel elections Family of Tyler Robinson's transgender lover speaks ...

Accurate disease detection is of paramount importance for effective medical treatment and patient care. However, the process of disease detection is often associated with extensive medical testing and considerable costs, making it impractical to perform all possible medical tests on a patient to diagnose or predict hundreds or thousands of diseases. In this work, we propose Collaborative Learning for Disease Detection (CLDD), a novel graph-based deep learning model that formulates disease detection as a collaborative learning task by exploiting associations among diseases and similarities among patients adaptively. CLDD integrates patient-disease interactions and demographic features from electronic health records to detect hundreds or thousands of diseases for every patient, with little to no reliance on the corresponding medical tests. Extensive experiments on a processed version of the MIMIC-IV dataset comprising 61,191 patients and 2,000 diseases demonstrate that CLDD consistently outperforms representative baselines across multiple metrics, achieving a 6.33\% improvement in recall and 7.63\% improvement in precision. Furthermore, case studies on individual patients illustrate that CLDD can successfully recover masked diseases within its top-ranked predictions, demonstrating both interpretability and reliability in disease prediction. By reducing diagnostic costs and improving accessibility, CLDD holds promise for large-scale disease screening and social health security.

We thank the reviewers for their positive and constructive comments. Bayes under model misspecification is an interesting addition to the theory of variational Bayes literature. Below we respond to the main comments. R1 finds the presentation in Section 2.2 and Assumptions 4 & 5 in Section 2.3 repetitive. Thank you for pointing it out.

We thank the reviewers for the insightful reviews and valuable suggestions. We address the comments as follows. Provide proof of Lemma 1: The proof of Lemma 1 uses induction. We will add the proof to the supplementary. Y es, as defined in Section 2.1.

Objective. Type 2 diabetes mellitus (T2DM) is a highly prevalent non-communicable chronic disease that substantially reduces life expectancy. Accurate estimation of all-cause mortality risk in T2DM patients is crucial for personalizing and optimizing treatment strategies. Research Design and Methods. This study analyzed a cohort of 554 patients (aged 40-87 years) with diagnosed T2DM over a maximum follow-up period of 16.8 years, during which 202 patients (36%) died. Key survival-associated features were identified, and multiple machine learning (ML) models were trained and validated to predict all-cause mortality risk. To improve model interpretability, Shapley additive explanations (SHAP) was applied to the best-performing model. Results. The extra survival trees (EST) model, incorporating ten key features, demonstrated the best predictive performance. The model achieved a C-statistic of 0.776, with the area under the receiver operating characteristic curve (AUC) values of 0.86, 0.80, 0.841, and 0.826 for 5-, 10-, 15-, and 16.8-year all-cause mortality predictions, respectively. The SHAP approach was employed to interpret the model's individual decision-making processes. Conclusions. The developed model exhibited strong predictive performance for mortality risk assessment. Its clinically interpretable outputs enable potential bedside application, improving the identification of high-risk patients and supporting timely treatment optimization.

Cardiovascular disease and chronic kidney disease are major complications of diabetes, leading to high morbidity and mortality. Early detection of these conditions is critical, yet traditional diagnostic markers often lack sensitivity in the initial stages. This study integrates conventional statistical methods with machine learning approaches to improve early diagnosis of CKD and CVD in diabetic patients. Descriptive and inferential statistics were computed in SPSS to explore associations between diseases and clinical or demographic factors. Patients were categorized into four groups: Group A both CKD and CVD, Group B CKD only, Group C CVD only, and Group D no disease. Statistical analysis revealed significant correlations: Serum Creatinine and Hypertension with CKD, and Cholesterol, Triglycerides, Myocardial Infarction, Stroke, and Hypertension with CVD. These results guided the selection of predictive features for machine learning models. Logistic Regression, Support Vector Machine, and Random Forest algorithms were implemented, with Random Forest showing the highest accuracy, particularly for CKD prediction. Ensemble models outperformed single classifiers in identifying high-risk diabetic patients. SPSS results further validated the significance of the key parameters integrated into the models. While challenges such as interpretability and class imbalance remain, this hybrid statistical machine learning framework offers a promising advancement toward early detection and risk stratification of diabetic complications compared to conventional diagnostic approaches.

Machine learning in healthcare requires effective representation of structured medical codes, but current methods face a trade-off: knowledge graph-based approaches capture formal relationships but miss real-world patterns, while data-driven methods learn empirical associations but often overlook structured knowledge in medical terminologies. We present KEEP (Knowledge-preserving and Empirically refined Embedding Process), an efficient framework that bridges this gap by combining knowledge graph embeddings with adaptive learning from clinical data. KEEP first generates embeddings from knowledge graphs, then employs regularized training on patient records to adaptively integrate empirical patterns while preserving ontological relationships. Importantly, KEEP produces final embeddings without task-specific axillary or end-to-end training enabling KEEP to support multiple downstream applications and model architectures. Evaluations on structured EHR from UK Biobank and MIMIC-IV demonstrate that KEEP outperforms both traditional and Language Model-based approaches in capturing semantic relationships and predicting clinical outcomes. Moreover, KEEP's minimal computational requirements make it particularly suitable for resource-constrained environments. Data and Code Availability This research has been conducted using data from UK Biobank (Sud-low et al., 2015) and MIMIC-IV Johnson et al. (2021). Researchers can request access via https:// www.ukbiobank.ac.uk/ and https://physionet.

We thank the anonymous reviewers for their enthusiasm and detailed comments on the manuscript. We start by addressing R2's concerns as they had the lowest score. This link is explicit as shown in this paper. The choice of kernel/activation function is up to the modelling task and'expert We merely provide a building block. The Matérn is a widely used prior, and worth adding to the NN tool set.